Literature DB >> 12787418

Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease.

Raffi Merjanian1, Matthew Budoff, Sharon Adler, Nancy Berman, Rajnish Mehrotra.   

Abstract

BACKGROUND: Individuals with end-stage renal disease (ESRD) have highly prevalent and severe vascular and valvular calcification. We undertook this study to test the hypothesis that vascular and valvular calcification begins and is often severe long before diabetic renal disease progresses to ESRD.
METHODS: A total of 32 nondialyzed individuals with type 2 diabetes mellitus and diabetic renal disease (albumin excretion rate>30 microg/min) [mean glomerular filtration rate (GFR), 49.8 +/- 6.1 mL/min/1.73 m2] were identified and compared with a group of 18 normoalbuminuric diabetics. We used 3:1 matching to identify 95 nondiabetic controls without renal disease, matched for age, gender, ethnicity, and the presence/absence of dyslipidemia, hypertension, and known coronary artery disease (CAD).
RESULTS: Using electron beam computed tomography (CT), the prevalence of coronary artery calcification was significantly greater among diabetic renal disease individuals (prevalence, 94% vs. 59%, P < 0.001; median score, 238 vs. 10, P < 0.001) than the nondiabetic controls. The coronary artery calcification scores were significantly more severe among diabetic renal disease individuals than either the diabetic or nondiabetic controls. Among individuals with diabetic renal disease, the coronary artery calcification and aortic wall calcification scores were several-fold greater among those with known CAD than among those without. There was also a significantly greater prevalence of aortic and mitral valve calcification among diabetic renal disease individuals than nondiabetic controls (aortic, 23% vs. 6%, P = 0.03; mitral, 25% vs. 2%, P < 0.001). Multivariate analysis using all three groups reproduced these findings and also consistently identified age and diabetic renal disease as additional predictors for the presence or severity of coronary artery and aortic wall calcification.
CONCLUSION: In this first, systematic analysis among nondialyzed individuals with diabetic renal disease, these data demonstrate that vascular and valvular calcification is present and often severe long before the disease progresses to ESRD. The data also suggest that the coronary artery and aortic wall calcification may represent atherosclerosis.

Entities:  

Mesh:

Year:  2003        PMID: 12787418     DOI: 10.1046/j.1523-1755.2003.00068.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

Review 1.  The connections between vascular calcification and bone health.

Authors:  Jorge B Cannata-Andia; Pablo Roman-Garcia; Keith Hruska
Journal:  Nephrol Dial Transplant       Date:  2011-11       Impact factor: 5.992

2.  The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

Authors:  G London; D Coyne; K Hruska; H H Malluche; K J Martin
Journal:  Clin Nephrol       Date:  2010-12       Impact factor: 0.975

3.  Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Matthew J Budoff; Daniel J Rader; Muredach P Reilly; Emile R Mohler; Jim Lash; Wei Yang; Leigh Rosen; Melanie Glenn; Valerie Teal; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2011-07-23       Impact factor: 8.860

Review 4.  Linking uric acid metabolism to diabetic complications.

Authors:  Akifumi Kushiyama; Kentaro Tanaka; Shigeko Hara; Shoji Kawazu
Journal:  World J Diabetes       Date:  2014-12-15

5.  Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up.

Authors:  Renato Watanabe; Marcelo M Lemos; Silvia R Manfredi; Sérgio A Draibe; Maria Eugênia F Canziani
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

6.  Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.

Authors:  Stuart M Sprague; Hanna Abboud; Ping Qiu; Matthew Dauphin; Pinggao Zhang; William Finn
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 8.237

7.  Coronary-artery calcium scores using electron beam CT in patients with chronic renal failure.

Authors:  Chan-Duck Kim; Ji-Hyung Cho; Hyuk-Joon Choi; Min-Hwa Jang; Hyeog-Man Kwon; Jun-Chul Kim; Sun-Hee Park; Jong-Min Lee; Dong-Kyu Cho; Yong-Lim Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

8.  Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?

Authors:  Merita Rroji; Saimir Seferi; Majlinda Cafka; Elizana Petrela; Erjola Likaj; Myftar Barbullushi; Nestor Thereska; Goce Spasovski
Journal:  Int Urol Nephrol       Date:  2013-04-17       Impact factor: 2.370

9.  Using a filtration technique to isolate platelet free plasma for assaying pyrophosphate.

Authors:  Ramin Tolouian; Sean M Connery; W Charles O'Neill; Ajay Gupta
Journal:  Clin Lab       Date:  2012       Impact factor: 1.138

10.  Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.

Authors:  Benjamin D Parker; Joachim H Ix; Ellen C M Cranenburg; Cees Vermeer; Mary A Whooley; Leon J Schurgers
Journal:  Nephrol Dial Transplant       Date:  2009-02-09       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.